MycC peptide
Not For Human Use, Lab Use Only.
Cat.#: 311956
Special Price 140.80 USD
-
Product Name
MycC peptide
-
Documents
Batch to batch variation of the purity
-
Sequence Shortening
YEQLRNSRA
-
Sequence
H-Tyr-Glu-Gln-Leu-Arg-Asn-Ser-Arg-Ala-OH
-
Length (aa)
9
-
Peptide Purity (HPLC)
95.6%
-
Molecular Formula
C47H77N17O16
-
Molecular Weight
1136.23
-
CAS No.
321914-26-5
-
Source
Synthetic
-
Form
Powder
-
Description
YEQLRNSRA corresponds to the carboxy-terminal octapeptide sequence of the v-myc-encoded transforming protein p110 of avian oncovirus MC29, predicted from nucleotide sequence analysis. In the reported study, a synthetic peptide of sequence Tyr-Glu-Gln-Leu-Arg-Asn-Ser-Arg-Ala was prepared, with the amino-terminal tyrosine added for coupling purposes and not part of the native protein sequence. Rabbit antisera raised against this peptide were used to immunoprecipitate proteins from cells transformed by MC29, CMII, and OK10, specifically recognizing the gag-myc hybrid proteins p110, p90, and p200, while failing to react with gag or pol precursor proteins or with the MH2-encoded p100.
The anti-peptide sera also precipitated putative gag-unrelated v-myc products, including a 60K protein from OK10-transformed cells and a 59K/61K doublet from MH2-transformed cells, as well as the truncated gag-myc proteins of the partially transformation-defective MC29 mutants tdlOA, tdlOC, and tdlOH and the variant HBI. Precipitation was inhibited by preabsorption with the synthetic peptide, confirming that the carboxy-terminal sequences are shared among these proteins. These findings indicate that the extreme carboxy-terminal region of v-myc is conserved across independently isolated MC29-type viruses and their derivatives.
-
Storage Guidelines
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
-
References
- Patschinsky T, Walter G, Bister K. Immunological analysis of v-myc gene products using antibodies against a myc-specific synthetic peptide. Virology. 1984 Jul 30;136(2):348-58. doi: 10.1016/0042-6822(84)90171-5. PMID: 6331679.
-
About TFA salt
Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.
Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.
Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.
In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.
- Molar Concentration Calculator
- Dilution Calculator
- Percent Concentration Calculator
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
Related Products / Services
• Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.
• Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.
• Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"